Exposure to exogenous insulin promotes IgG1 and the T-helper 2- associated IgG4 responses to insulin but not to other islet autoantigens

Diabetes

Volumn 49, Issue 6, 2000, Pages 918-925

  Füchtenbusch, Martin ^a   Kredel, Katharina ^a,b   Bonifacio, Ezio ^a,b   Schnell, Oliver ^a   Ziegler, Anette Gabriele ^a,c  

^a Klinikum Schwabing   (Germany)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYCLOSPORIN A; GLUTAMATE DECARBOXYLASE; IA ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; INSULIN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PLACEBO;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; PANCREAS ISLET; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RELATIVE; TH2 CELL;

EID: 0342657186     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.6.918     Document Type: Article

References (36)

1. Eisenbarth GS: Primer immunology/autoimmunity. In Type I Diabetes: Molecular; Cellular and Clinical Immunology. Eisenbarth GS, Lafferty KJ, Eds. New York, Oxford University Press, 1996, p. 3-18
2. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T-cell self-tolerance to glutamic acid decarboxylase is a key event in the pathogenesis of murine insulin-dependent diabetes. Nature 366:69-71, 1993
3. Muir A, Peck A, Clare-Salzler MC, Song YH, Cornelius J, Luchetta R, Krischer J, Maclaren N: Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J Clin Invest 95:628-634, 1995
4. Daniel D, Wegmann DR: Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci U S A 93:956-960, 1996
5. Karounos DG, Bryson JS, Cohen DA: Metabolically inactive insulin analogue prevents type 1 diabetes in prediabetic NOD mice. J Clin Invest 100:1344-1348, 1997
6. Tian J, Chau C, Kaufman DL: Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in prediabetic mice. Diabetologia 41:237-240, 1998
7. Tian J, Olcott AP, Hanssen LR, Zekzer D, Middleton B, Kaufman DL: Infectious Th1 and Th2 autoimmunity in diabetes-prone mice. Immunol Rev 164:119-127, 1998
8. Keller RJ, Eisenbarth GS, Jackson RA: Insulin prophylaxis in individuals at high risk of type 1 diabetes. Lancet 341:927-928, 1993
9. Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler AG: Delay of type 1 diabetes in high risk, first-degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial. Diabetologia 41:536-541, 1998
10. Shaw SC, John JI, Simpson NE: A randomized trial of intensive therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med 320:550-554, 1989
11. Schnell O, Eisfelder B, Standl E, Ziegler A-G: High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM. Diabetes 46:1607-1611, 1997
12. Stevens TL, Bossie A, Sanders VM, Fernandez-Botran R, Coffman RL, Mosmann TR, Vitetta ES: Regulation of antibody isotype secretion by subsets of antigen-specific helper T-cells. Nature 334:255-258, 1988
13. Snapper CM, Paul WE: Interferon-γ and β-cell-stimulatory factor-1 reciprocally regulates Ig isotype production. Science 236:944-947, 1987
14. Lundgren M, Persson U, Lansson P, Magnusson C, Smith CIE, Hammarstrom L, Sverinson E: Interleukin 4 induces synthesis of IgE and IgG4 in human β cells. Eur J Immunol 19:1311-1315, 1989
15. Soeldner JS, Slone D: Critical variables in the radioimmunoassay of serum insulin using the double antibody technique. Diabetes 14:771-779, 1965
16. Canadian European Randomized Control Trial Group: Cyclosporin-induced remission of IDDM after early intervention: association of 1 year of cyclosporin treatment with enhanced insulin secretion. Diabetes 37:1574-1582, 1988
17. Martin S, Schernthaner G, Nerup J, Gries FA, Koivisto VA, Dupre J, Standl E, Hamet P, McArthur R, Tan MH, Dawson K, Metha AE, Van Vliet S, Graffenried B, Stiller C, Kolb H, on behalf of the Canadian/European Randomized Controlled Trial Group. Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects: Diabetologia 34:429-434, 1991
18. Naserke H, Dozio N, Ziegler AG, Bonifacio E: Comparison of a novel microassay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 41:681-683, 1998
19. Bonifacio E, Scirpoli M, Kredel K, Füchtenbusch M, Ziegler A-G: Early autoantibody responses in prediabetes are IgG1-dominated and suggest antigen-specific regulation. J Immunol 163:525-532, 1999
20. Palmer JP, Helqvist S, Spinas GA, Molvig J: Interaction of β-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 38:1211-1216, 1989
21. Aaen K, Rygaard J, Josefsen K, Petersen H, Brogren CH, Horn T, Buschard K: Dependence of antigen expression on functional state of β-cells. Diabetes 39:697-701, 1990
22. Bertrand S, De Paepe M, Vigeant C, Yale JF: Prevention of adoptive transfer in BB rats by prophylactic insulin treatment. Diabetes 41:1273-1275, 1992
23. Zhang ZJ, Davidson L, Eisenbarth GS, Weiner HL: Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A 88:10252-10256, 1991
24. + T-cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 11:463-472, 1999
25. + regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector cells. Diabetes 48:1720-1729, 1999
26. Stavnezer J: Immunoglobulin class switching. Curr Opin Immunol 8:199-205, 1996
27. King CL, Nutman TB: IgE and IgG subclass regulation by IL-4 and IFN-γ in human helminth infections: assessment by β-cell precursor frequencies. J Immunol 141:458-465, 1993
28. Bidet B, Beauvais F, Timsit J, Descours B, Chauveau ME, Benveniste J: Presence of anti-insulin reaginic auto-antibodies of the IgG4 class in insulin-dependent (type I) diabetic patients before insulin therapy. Int Arch Allergy Immunol 102:127-132, 1993
29. Fulcher CA, de Graaf Mahoney S, Zimmerman TS: FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting. Blood 69:1475-1480, 1987
30. Berman MA, Sandborg CI, Wang Z, Imfeld KL, Zaldivar F Jr, Daufalza V, Buckingham BA: Decreased IL-4 production in new-onset type 1 insulin-dependent diabetes mellitus. J Immunol 157:4690-4696, 1996
31. Rapoport MJ, Mor A, Vardi P, Ramot Y, Winkler R, Hindi A, Bistritzer T: Decreased secretion of Th2 cytokines precedes up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. J Autoimmun 11:635-642, 1998
32. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA: Extreme Th1 bias of invariant V α24JαQ T cells in type 1 diabetes. Nature 391:177-181, 1998
33. Jacobs MJ, van den Hoek AE, van de Putte LB, van den Berg WB: Anergy of antigen-specific T lymphocytes is a potent mechanism of intravenously induced tolerance. Immunology 82:294-300, 1994
34. Mandrup-Poulsen T, Nerup J, Stiller CR, Marner B, Bille G, Heinrichs D, Martell R, Dupre J, Keown PA, Jenner MR: Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics. Lancet i:599-602, 1985
35. Boitard C, Feutren G, Castano L, Debray-Sachs M, Assan R, Hors J, Bach JF: Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients. J Clin Invest 80:1607-1612, 1987
36. Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, Mayer A, Czerkinsky C, Holmgren J, Thivolet C: A cholera toxoid insulin conjugate as oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci U S A 94:4610-4614, 1997